BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Treatment
137 results:

  • 1. Hinokitiol Inhibits breast cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/SOX2/oct4 Pathway.
    Chiang YF; Huang KC; Chen HY; Hamdy NM; Huang TC; Chang HY; Shieh TM; Huang YJ; Hsia SM
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612715
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Changes in lymph node surgery in breast cancer and preoperative drug prescription analysis for postoperative pain management: A retrospective, cross-sectional study.
    Kang ES; Lim YC; Jang BH; Lee YJ; Ha IH; Lee YS
    PLoS One; 2024; 19(4):e0298270. PubMed ID: 38574043
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features.
    Leiva MC; Gustafsson A; Garre E; Ståhlberg A; Kovács A; Helou K; Landberg G
    J Transl Med; 2023 Dec; 21(1):924. PubMed ID: 38124067
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Estrogen-Related Receptor Alpha (ERRα) Promotes cancer Stem Cell-Like Characteristics in breast cancer.
    Muduli K; Prusty M; Pradhan J; Samal AP; Sahu B; Roy DS; Reddy KS; Elangovan S
    Stem Cell Rev Rep; 2023 Nov; 19(8):2807-2819. PubMed ID: 37584854
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The deformation of cancer cells through narrow micropores holds the potential to regulate genes that impact cancer malignancy.
    Choi JS; Lee SH; Park HB; Chun C; Kim Y; Kim KH; Weon BM; Kim DH; Kim HJ; Lee JH
    Lab Chip; 2023 Aug; 23(16):3628-3638. PubMed ID: 37448298
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative breast cancer MDA-MB-231 Cells.
    Pratelli G; Carlisi D; Di Liberto D; Notaro A; Giuliano M; D'Anneo A; Lauricella M; Emanuele S; Calvaruso G; De Blasio A
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446326
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
    Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
    J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Estrogen Receptor β4 Regulates Chemotherapy Resistance and Induces cancer Stem Cells in Triple Negative breast cancer.
    Bano A; Stevens JH; Modi PS; Gustafsson JÅ; Strom AM
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982940
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBC.
    Marni R; Malla M; Chakraborty A; Malla R
    Life Sci; 2023 May; 320():121534. PubMed ID: 36889667
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Total flavonoids of Litchi seed attenuate stem cell-like properties in breast cancer by regulating Notch3 signaling pathway.
    Liao Y; Luo Z; Liu Y; Xue W; He S; Chen X; Ren H; Yang X; Zhu D; Su Z; Huang Q; Guo H
    J Ethnopharmacol; 2023 Apr; 305():116133. PubMed ID: 36603788
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Association of Hormone Therapy With Depression During Menopause in a Cohort of Danish Women.
    Wium-Andersen MK; Jørgensen TSH; Halvorsen AH; Hartsteen BH; Jørgensen MB; Osler M
    JAMA Netw Open; 2022 Nov; 5(11):e2239491. PubMed ID: 36318208
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Withaferin A mediated changes of miRNA expression in breast cancer-derived mammospheres.
    Prajapati KS; Shuaib M; Gupta S; Kumar S
    Mol Carcinog; 2022 Sep; 61(9):876-889. PubMed ID: 35770722
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Counterintuitive production of tumor-suppressive secretomes from oct4- and c-Myc-overexpressing tumor cells and MSCs.
    Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
    Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
    [No Abstract]    [Full Text] [Related]  

  • 14. A novel role for aspirin in enhancing the reprogramming function of miR-302/367 cluster and breast tumor suppression.
    Rezania MA; Eghtedari A; Taha MF; Ardekani AM; Javeri A
    J Cell Biochem; 2022 Jun; 123(6):1077-1090. PubMed ID: 35535453
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway.
    Tsao AN; Chuang YS; Lin YC; Su Y; Chao TC
    Oncol Rep; 2022 May; 47(5):. PubMed ID: 35417031
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Stem gene expression in breast tumors during chemotherapy: Connection with the main clinical and morphological factors and the disease outcome.
    Ibragimova MK; Tsyganov MM; Deryusheva IV; Slonimskaya EM; Litviakov NV
    J Cancer Res Ther; 2022; 18(1):89-95. PubMed ID: 35381768
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. FOXM1 mediates GDF-15 dependent stemness and intrinsic drug resistance in breast cancer.
    Modi A; Purohit P; Roy D; Vishnoi JR; Pareek P; Elhence P; Singh P; Sharma S; Sharma P; Misra S
    Mol Biol Rep; 2022 Apr; 49(4):2877-2888. PubMed ID: 35066766
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil.
    Nandi SK; Roychowdhury T; Chattopadhyay S; Basu S; Chatterjee K; Choudhury P; Banerjee N; Saha P; Mukhopadhyay S; Mukhopadhyay A; Bhattacharya R
    Toxicol Appl Pharmacol; 2022 Feb; 437():115887. PubMed ID: 35063459
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
    Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
    Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative breast cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro.
    Choi HS; Ko YS; Jin H; Kang KM; Ha IB; Jeong H; Song HN; Kim HJ; Jeong BK
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500557
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.